Doximity Investors Face November Deadline in Securities Class Action

Investors who purchased Doximity, Inc. common stock between August 8, 2024, and May 13, 2026, have until November 16, 2026, to apply for lead plaintiff status. The class action lawsuit, filed in the Northern District of California, accuses the digital health platform of misleading shareholders regarding revenue growth and competitive market position.

Money Talk·October 22, 2026·reads: 288

The litigation, Michigan Laborers' Pension Fund v. Doximity, Inc., alleges that company executives violated the Securities Exchange Act of 1934 by overstating the influence of the firm’s Newsfeed on financial performance. Plaintiffs claim Doximity masked the reality that it was losing market share to competitors who employed more effective pricing and engagement strategies, relying instead on basic banner ads and e-newsletters.

Stock prices suffered three distinct declines following disclosures from the company. On November 6, 2025, shares dropped 13% after management signaled a slowdown in sales. A subsequent reduction in revenue guidance on February 5, 2026, triggered a 17% decline. The final blow occurred on May 13, 2026, when the company missed its lowered revenue targets and projected decelerated growth for the 2027 fiscal year, leading to a 23% share price drop.

Robbins Geller Rudman & Dowd LLP is representing the class. Investors seeking to lead the litigation must demonstrate a significant financial interest and satisfy the requirements of the Private Securities Litigation Reform Act of 1995. Participation as a lead plaintiff is not required to share in any potential future recovery.